Skip to main content
. 2015 Aug 28;8:2361–2374. doi: 10.2147/OTT.S87298

Figure 5.

Figure 5

Trial sequential analysis of 27 trials with lower risk of bias reporting severe infections.

Abbreviation: VEGFR-TKIs, vascular endothelial growth factor receptor tyrosine kinase inhibitors.